Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
By Deena BeasleyDec 14 (Reuters) - The Omicron coronavirus variant has been detected in 77 countries since it was first identified three weeks ago, fueling concerns that its large number of mutations will help it spread faster and evade protection...
Read more(Adds details from the Elliott letter, analyst comment)By Aby Jose Koilparambil and Yadarisa ShabongDec 10 (Reuters) - Activist investor Elliott called on Friday for Britain's Taylor Wimpey to replace its departing chief executive Pete Redfern with...
Read more(Adds Taylor Wimpey response)By Aby Jose Koilparambil and Yadarisa ShabongDec 10 (Reuters) - Activist investor Elliott called on Friday for Britain's Taylor Wimpey to replace its departing chief executive Pete Redfern with an external candidate, s...
Read more
(Sharecast News) - Medicago and GSK's Covid-19 vaccine showed a high degree of efficacy in blocking symptomatic disease in those infected with the Delta strain of SARS-CoV-2.
Read more
TOP NEWS: Glaxo gets positive test results for plant-based Covid jab
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Tech stocks surge after recent selloff* China policy easing lifts miners* Defensive stocks see selling (Updates to close)By Anisha Sircar ...
Read moreIN BRIEF: Glaxo says further tests show Covid-19 drug fights Omicron
Read more(Sharecast News) - GlaxoSmithKline and Vir Biotechnology on Tuesday said their antibody Covid-19 treatment was effective against all mutations of the Omicron variant, according to early-stage studies.
Read moreLONDON MARKET CLOSE: Stocks fall as Omicron variant fears mount
Read more(Corrects description to inactivated virus, in paragraph 1)Dec 2 (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the inactivated-virus COVID-19 vaccine from French biotech firm Valneva, weeks aft...
Read more(adds Valneva comment on Omicron variant)Dec 2 (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm Valneva, weeks after the EU signed a dea...
Read moreLONDON MARKET OPEN: Mood switches again after Omicron detected in US
Read moreTOP NEWS: GSK says Covid-19 treatment works against Omicron variant
Read moreLONDON BRIEFING: GlaxoSmithKline's Covid treatment copes with Omicron
Read more* Sotrovimab, developed with Vir, tested in lab and on hamsters* Key Omicron mutations did not elude drug activity in study* Tests continuing on further mutations (Adds methods, chief scientist's comment)By Ludwig BurgerDec 2 (Reuters) - Laboratory...
Read more
Last checked at